Global Drugs for Malaria Market Growth 2021-2026

March 2021 | 130 pages | ID: G056AE4EAABEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this latest study, the 2021 growth of Drugs for Malaria will have significant change from previous year. By the most conservative estimates of global Drugs for Malaria market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Drugs for Malaria market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Malaria market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

• Prevention
• Treatment
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Malaria Consumption 2016-2026
  2.1.2 Drugs for Malaria Consumption CAGR by Region
2.2 Drugs for Malaria Segment by Type
  2.2.1 Aryl Aminoalcohol Compounds
  2.2.2 Antifolate Compounds
  2.2.3 Artemisinin Compounds
2.3 Drugs for Malaria Sales by Type
  2.3.1 Global Drugs for Malaria Sales Market Share by Type (2016-2021)
  2.3.2 Global Drugs for Malaria Revenue and Market Share by Type (2016-2021)
  2.3.3 Global Drugs for Malaria Sale Price by Type (2016-2021)
2.4 Drugs for Malaria Segment by Application
  2.4.1 Prevention
  2.4.2 Treatment
  2.4.3 Others
2.5 Drugs for Malaria Sales by Application
  2.5.1 Global Drugs for Malaria Sale Market Share by Application (2016-2021)
  2.5.2 Global Drugs for Malaria Revenue and Market Share by Application (2016-2021)
  2.5.3 Global Drugs for Malaria Sale Price by Application (2016-2021)

3 GLOBAL DRUGS FOR MALARIA BY COMPANY

3.1 Global Drugs for Malaria Sales Market Share by Company
  3.1.1 Global Drugs for Malaria Sales by Company (2019-2021)
  3.1.2 Global Drugs for Malaria Sales Market Share by Company (2019-2021)
3.2 Global Drugs for Malaria Revenue Market Share by Company
  3.2.1 Global Drugs for Malaria Revenue by Company (2019-2021)
  3.2.2 Global Drugs for Malaria Revenue Market Share by Company (2019-2021)
3.3 Global Drugs for Malaria Sale Price by Company
3.4 Global Manufacturers Drugs for Malaria Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Drugs for Malaria Product Location Distribution
  3.4.2 Players Drugs for Malaria Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DRUGS FOR MALARIA BY REGION

4.1 Global Drugs for Malaria by Region
  4.1.1 Global Drugs for Malaria Sales by Region
  4.1.2 Global Drugs for Malaria Revenue by Region
4.2 Americas Drugs for Malaria Sales Growth
4.3 APAC Drugs for Malaria Sales Growth
4.4 Europe Drugs for Malaria Sales Growth
4.5 Middle East & Africa Drugs for Malaria Sales Growth

5 AMERICAS

5.1 Americas Drugs for Malaria Sales by Country
  5.1.1 Americas Drugs for Malaria Sales by Country (2016-2021)
  5.1.2 Americas Drugs for Malaria Revenue by Country (2016-2021)
5.2 Americas Drugs for Malaria Sales by Type
5.3 Americas Drugs for Malaria Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drugs for Malaria Sales by Region
  6.1.1 APAC Drugs for Malaria Sales by Region (2016-2021)
  6.1.2 APAC Drugs for Malaria Revenue by Region (2016-2021)
6.2 APAC Drugs for Malaria Sales by Type
6.3 APAC Drugs for Malaria Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Drugs for Malaria by Country
  7.1.1 Europe Drugs for Malaria Sales by Country (2016-2021)
  7.1.2 Europe Drugs for Malaria Revenue by Country (2016-2021)
7.2 Europe Drugs for Malaria Sales by Type
7.3 Europe Drugs for Malaria Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Malaria by Country
  8.1.1 Middle East & Africa Drugs for Malaria Sales by Country (2016-2021)
  8.1.2 Middle East & Africa Drugs for Malaria Revenue by Country (2016-2021)
8.2 Middle East & Africa Drugs for Malaria Sales by Type
8.3 Middle East & Africa Drugs for Malaria Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Drugs for Malaria Distributors
10.3 Drugs for Malaria Customer

11 GLOBAL DRUGS FOR MALARIA MARKET FORECAST

11.1 Global Drugs for Malaria Forecast by Region
  11.1.1 Global Drugs for Malaria Forecast by Regions (2021-2026)
  11.2.2 Global Drugs for Malaria Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Drugs for Malaria Forecast by Type
11.7 Global Drugs for Malaria Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Cipla
  12.1.1 Cipla Company Information
  12.1.2 Cipla Drugs for Malaria Product Offered
  12.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.1.4 Cipla Main Business Overview
  12.1.5 Cipla Latest Developments
12.2 Guilin Pharmaceutical
  12.2.1 Guilin Pharmaceutical Company Information
  12.2.2 Guilin Pharmaceutical Drugs for Malaria Product Offered
  12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.2.4 Guilin Pharmaceutical Main Business Overview
  12.2.5 Guilin Pharmaceutical Latest Developments
12.3 IPCA Laboratories
  12.3.1 IPCA Laboratories Company Information
  12.3.2 IPCA Laboratories Drugs for Malaria Product Offered
  12.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.3.4 IPCA Laboratories Main Business Overview
  12.3.5 IPCA Laboratories Latest Developments
12.4 GlaxoSmithKline
  12.4.1 GlaxoSmithKline Company Information
  12.4.2 GlaxoSmithKline Drugs for Malaria Product Offered
  12.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.4.4 GlaxoSmithKline Main Business Overview
  12.4.5 GlaxoSmithKline Latest Developments
12.5 Mylan Labs
  12.5.1 Mylan Labs Company Information
  12.5.2 Mylan Labs Drugs for Malaria Product Offered
  12.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.5.4 Mylan Labs Main Business Overview
  12.5.5 Mylan Labs Latest Developments
12.6 Roche
  12.6.1 Roche Company Information
  12.6.2 Roche Drugs for Malaria Product Offered
  12.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.6.4 Roche Main Business Overview
  12.6.5 Roche Latest Developments
12.7 Novartis
  12.7.1 Novartis Company Information
  12.7.2 Novartis Drugs for Malaria Product Offered
  12.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.7.4 Novartis Main Business Overview
  12.7.5 Novartis Latest Developments
12.8 Sanofi Aventis
  12.8.1 Sanofi Aventis Company Information
  12.8.2 Sanofi Aventis Drugs for Malaria Product Offered
  12.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.8.4 Sanofi Aventis Main Business Overview
  12.8.5 Sanofi Aventis Latest Developments
12.9 Ajanta Pharma
  12.9.1 Ajanta Pharma Company Information
  12.9.2 Ajanta Pharma Drugs for Malaria Product Offered
  12.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2019-2021)
  12.9.4 Ajanta Pharma Main Business Overview
  12.9.5 Ajanta Pharma Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Drugs for Malaria Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Aryl Aminoalcohol Compounds
Table 3. Major Players of Antifolate Compounds
Table 4. Major Players of Artemisinin Compounds
Table 5. Global Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 6. Global Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 7. Global Drugs for Malaria Revenue by Type (2016-2021) & ($ million)
Table 8. Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
Table 9. Global Drugs for Malaria Sale Price by Type (2016-2021)
Table 10. Global Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 11. Global Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 12. Global Drugs for Malaria Value by Application (2016-2021)
Table 13. Global Drugs for Malaria Revenue Market Share by Application (2016-2021)
Table 14. Global Drugs for Malaria Sale Price by Application (2016-2021)
Table 15. Global Drugs for Malaria Sales by Company (2019-2021) & (K Units)
Table 16. Global Drugs for Malaria Sales Market Share by Company (2019-2021)
Table 17. Global Drugs for Malaria Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Drugs for Malaria Revenue Market Share by Company (2019-2021)
Table 19. Global Drugs for Malaria Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Drugs for Malaria Producing Area Distribution and Sales Area
Table 21. Players Drugs for Malaria Products Offered
Table 22. Drugs for Malaria Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drugs for Malaria Sales by Region (2016-2021) (K Units)
Table 26. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 27. Global Drugs for Malaria Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Drugs for Malaria Revenue Market Share by Region (2016-2021)
Table 29. Americas Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 30. Americas Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 31. Americas Drugs for Malaria Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 33. Americas Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 34. Americas Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 35. Americas Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 36. Americas Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 37. APAC Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 38. APAC Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 39. APAC Drugs for Malaria Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Drugs for Malaria Revenue Market Share by Region (2016-2021)
Table 41. APAC Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 42. APAC Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 43. APAC Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 44. APAC Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 45. Europe Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 46. Europe Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 47. Europe Drugs for Malaria Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 49. Europe Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 50. Europe Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 51. Europe Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 52. Europe Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Drugs for Malaria Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Drugs for Malaria Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Drugs for Malaria Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Drugs for Malaria
Table 62. Key Application and Potential Industries of Drugs for Malaria
Table 63. Key Challenges of Drugs for Malaria
Table 64. Key Trends of Drugs for Malaria
Table 65. Drugs for Malaria Distributors List
Table 66. Drugs for Malaria Customer List
Table 67. Global Drugs for Malaria Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Drugs for Malaria Consumption Market Forecast by Region
Table 69. Global Drugs for Malaria Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Drugs for Malaria Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Drugs for Malaria Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Drugs for Malaria Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Drugs for Malaria Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Drugs for Malaria Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Drugs for Malaria Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Drugs for Malaria Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Drugs for Malaria Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Drugs for Malaria Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Drugs for Malaria Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Drugs for Malaria Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Drugs for Malaria Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Drugs for Malaria Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Drugs for Malaria Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Drugs for Malaria Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Drugs for Malaria Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Drugs for Malaria Revenue Market Share Forecast by Application (2021-2026)
Table 87. Cipla Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Drugs for Malaria Product Offered
Table 89. Cipla Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Cipla Main Business
Table 91. Cipla Latest Developments
Table 92. Guilin Pharmaceutical Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 93. Guilin Pharmaceutical Drugs for Malaria Product Offered
Table 94. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Guilin Pharmaceutical Main Business
Table 96. Guilin Pharmaceutical Latest Developments
Table 97. IPCA Laboratories Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 98. IPCA Laboratories Drugs for Malaria Product Offered
Table 99. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. IPCA Laboratories Main Business
Table 101. IPCA Laboratories Latest Developments
Table 102. GlaxoSmithKline Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 103. GlaxoSmithKline Drugs for Malaria Product Offered
Table 104. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. GlaxoSmithKline Main Business
Table 106. GlaxoSmithKline Latest Developments
Table 107. Mylan Labs Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Labs Drugs for Malaria Product Offered
Table 109. Mylan Labs Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 110. Mylan Labs Main Business
Table 111. Mylan Labs Latest Developments
Table 112. Roche Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 113. Roche Drugs for Malaria Product Offered
Table 114. Roche Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 115. Roche Main Business
Table 116. Roche Latest Developments
Table 117. Novartis Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Drugs for Malaria Product Offered
Table 119. Novartis Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Sanofi Aventis Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Aventis Drugs for Malaria Product Offered
Table 124. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 125. Sanofi Aventis Main Business
Table 126. Sanofi Aventis Latest Developments
Table 127. Ajanta Pharma Basic Information, Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors
Table 128. Ajanta Pharma Drugs for Malaria Product Offered
Table 129. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 130. Ajanta Pharma Main Business
Table 131. Ajanta Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Drugs for Malaria
Figure 2. Drugs for Malaria Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Malaria Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Drugs for Malaria Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Drugs for Malaria Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Aryl Aminoalcohol Compounds
Figure 10. Product Picture of Antifolate Compounds
Figure 11. Product Picture of Artemisinin Compounds
Figure 12. Global Drugs for Malaria Sales Market Share by Type in 2020
Figure 13. Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
Figure 14. Drugs for Malaria Consumed in Prevention
Figure 15. Global Drugs for Malaria Market: Prevention (2016-2021) & (K Units)
Figure 16. Drugs for Malaria Consumed in Treatment
Figure 17. Global Drugs for Malaria Market: Treatment (2016-2021) & (K Units)
Figure 18. Drugs for Malaria Consumed in Others
Figure 19. Global Drugs for Malaria Market: Others (2016-2021) & (K Units)
Figure 20. Global Drugs for Malaria Sales Market Share by Application (2016-2021)
Figure 21. Global Drugs for Malaria Revenue Market Share by Application in 2020
Figure 22. Drugs for Malaria Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Drugs for Malaria Revenue Market Share by Company in 2020
Figure 24. Global Drugs for Malaria Sales Market Share by Regions (2016-2021)
Figure 25. Global Drugs for Malaria Revenue Market Share by Region in 2020
Figure 26. Americas Drugs for Malaria Sales 2016-2021 (K Units)
Figure 27. Americas Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 28. APAC Drugs for Malaria Sales 2016-2021 (K Units)
Figure 29. APAC Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 30. Europe Drugs for Malaria Sales 2016-2021 (K Units)
Figure 31. Europe Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Drugs for Malaria Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Drugs for Malaria Revenue 2016-2021 ($ Millions)
Figure 34. Americas Drugs for Malaria Sales Market Share by Country in 2020
Figure 35. Americas Drugs for Malaria Revenue Market Share by Country in 2020
Figure 36. Americas Drugs for Malaria Sales Market Share by Type in 2020
Figure 37. Americas Drugs for Malaria Sales Market Share by Application in 2020
Figure 38. United States Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Drugs for Malaria Sales Market Share by Region in 2020
Figure 43. APAC Drugs for Malaria Revenue Market Share by Regions in 2020
Figure 44. APAC Drugs for Malaria Sales Market Share by Type in 2020
Figure 45. APAC Drugs for Malaria Sales Market Share by Application in 2020
Figure 46. China Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Drugs for Malaria Sales Market Share by Country in 2020
Figure 53. Europe Drugs for Malaria Revenue Market Share by Country in 2020
Figure 54. Europe Drugs for Malaria Sales Market Share by Type in 2020
Figure 55. Europe Drugs for Malaria Sales Market Share by Application in 2020
Figure 56. Germany Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Drugs for Malaria Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Drugs for Malaria Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Drugs for Malaria Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Drugs for Malaria Sales Market Share by Application in 2020
Figure 65. Egypt Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Drugs for Malaria Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles